loading

Our Vision

Re-defining
Medicine for the Coming
Generation

Curing incurable diseases by re-programming cell fate or function.

Passionate

Reliable

Achievers

Committed

Team players

Innovative

Courageous

Engaged

Values in PRACTICE

iRegene's
mission

We are a passionate team committed
to developing first-in-class therapies
for patients suffering from major
incurable diseases. Making fast-acting
and disease-reversing therapies accessible
to patients in the greatest extent
possible is our priority.

P

Passionate

A

Achievers

T

Team players

C

Courageous

Reliable

R

Committed

C

Innovative

I

Engaged

E

Next Generation R&D Eco-system, Made by iRegene

iReMeta

Discovering Omics, Powered by AI

iReChem

Deep Learning Assisted Virtual Screening

iReXam

Compounds Validation

iReDita

Gene Editing & Reporter Cell Lines

iReCena

Designing Exosomes for Therapeutics Delivery

Independent Pipelines & Cooperation Pipelines

Project

Indication

POC Pre-Clinical IND Phase I

Phase II Phase III

RIGHT

NouvNeu001

Parkinson′s Disease

2023 H2 Initiate Clinical Trials

NouvNeu003

Early-onset Parkinson's

2024 H2 Initiate Clinical Trials

NouvNeu002

Ischemic Stroke

NouvSight001

Retinal Degenerative Diseases

NouvHepa001

Liver Diseases

Contact

Wuhan Suzhou Denmark Singapore

iReMeta

Discovery Platform with the aid of AI Algorithms

• Omic analysis
• Information Learned from Patients
• Precise and distinctive models

Wuhan

Address

No. 9, Gaokeyuan 3rd Road, East Lake High-tech Development Zone, Wuhan

Tel.

(+86) 027-65522933 (+86) 027-59338180

Email

iregene@iregene.com

Suzhou

Address

218 Sang Tian Rd. BLDG 2 Rm.501 BioBAY Phase 2, Su Zhou Industrial Park Su Zhou, Jiang Su Province, 215000, China

Tel.

(+86) 186-9612-5803

Email

iregene@iregene.com

Denmark

Address

8000 Aarhus C, Denmark

Email

iregene@iregene.com

Singapore

Address

160 Robinson Road,#14-04 Singapore Business Federation Centre – Singapore 068914

Email

iregene@iregene.com